Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever and Neutropenia - Related Studies

Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever and Neutropenia

This study has been completed.

Study NCT00001790. Last updated on March 3, 2008. Information provided by National Institutes of Health Clinical Center (CC)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Fever
		Mycoses
		Neutropenia

2	More general conditions related to this trial
		Agranulocytosis
		Body Temperature Changes
		Hematologic Diseases
		Leukocyte Disorders
		Leukopenia
		Signs and Symptoms

3	Interventions listed in this trial
		FK463

4	Additional drug interventions recognized in this trial
		Micafungin

5	More general drug interventions related to this trial
		Anti-Infective Agents
		Antifungal Agents
		Pharmacologic Actions
		Therapeutic Uses

6	Sponsors listed in this trial
		National Cancer Institute (NCI)